MedPath
NMPA Approval

Sunitinib Malate Capsules

国药准字HJ20240157

December 1, 2024

Drug Information

苹果酸舒尼替尼胶囊

胶囊剂

12.5mg(按C₂₂H₂₇FN₄O₂计)

化学药品

December 1, 2024

November 30, 2029

Company Information

Applicant Company

Formulation Unit -VII, Plot Nos. P1 to P9, Phase-III, VSEZ, Duvvada, Visakhapatnam District 530046, Andhra Pradesh, India.

Manufacturing Company

Formulation Unit -VII, Plot Nos. P1 to P9, Phase-III, VSEZ, Duvvada, Visakhapatnam District 530046, Andhra Pradesh, India.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

苹果酸舒尼替尼胶囊 - NMPA 批准文号 | MedPath